Wacker Bio licenses its E. coli based production strain to PhaseBio
Wacker licenses E. coli based production strain to PhaseBio for the manufacture of antibody fragment.
Archives for May 6, 2019
‘No longer science-fiction’: Evolutions and applications of cell & gene therapies
According to an industry expert, gene therapy must move rapidly to address unmet needs and will continue to do so given innovation and investments.
Lonza serves small biotech with services to accelerate movement to the clinic
Lonza announces service offering to accelerate the movement of poorly-soluble small molecules into first-in-human clinical trials.
Sharp ‘future proofs’ manufacturing with facility investment
Sharp invests $21m to meet growing demand by expanding its capacity for packaging services at its Allentown, PA campus.